Biotech News

ANI Pharmaceuticals to Present at Upcoming December Investor Conference

ANI Pharmaceuticals (ANIP)ANI PharmaceuticalsConference / presentation

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in a fireside chat at the following upcoming investor conference:

Related news

ANI Pharmaceuticals

Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines. Cortrophin Gel Purified Cortrophin Gel is an adrenocorticotropic hormone...

Recent company news

Stock data

Close
69.13 USD
Market cap
1.7B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States